FMVB12B Inhibitors
FMVB12B inhibitors are a class of chemical compounds that specifically target the FMVB12B protein, a member of the F-box family of proteins. F-box proteins are essential components of the SCF (Skp1-Cul1-F-box) complex, a type of E3 ubiquitin ligase. This complex plays a key role in protein degradation through the ubiquitin-proteasome pathway, where F-box proteins serve as substrate recognition elements. FMVB12B is involved in regulating various cellular processes by mediating the ubiquitination and subsequent proteasomal degradation of target proteins. Inhibition of FMVB12B disrupts the function of the SCF complex, potentially affecting the stability of a range of substrates that are critical for cellular homeostasis.
The chemical structure of FMVB12B inhibitors typically includes functional groups that facilitate interaction with the FMVB12B protein, either by direct binding to the protein or by interfering with its interactions within the SCF complex. These inhibitors may vary in their specificity and affinity, but they generally work by preventing FMVB12B from properly recognizing and tagging its substrates for degradation. As a result, proteins that would normally be degraded accumulate within the cell. FMVB12B inhibitors are valuable research tools for studying the role of F-box proteins in cellular regulation, offering insight into how protein degradation influences processes like cell cycle progression, signal transduction, and cellular stress responses. The chemical properties and modes of action of these inhibitors make them essential for elucidating the molecular mechanisms behind proteostasis and ubiquitin-mediated degradation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
This pan-caspase inhibitor prevents the cleavage of caspases, which could be involved in the downstream degradation of Multivesicular Body Subunit 12B through apoptotic body formation. Inhibition of caspases ensures the integrity of the protein by preventing its potential degradation during apoptosis. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
This specific inhibitor of V-ATPase disrupts endosomal acidification, which is crucial for the endosome maturation where Multivesicular Body Subunit 12B functions. By inhibiting V-ATPase, the endosomal maturation is hindered, thereby inhibiting the function of Multivesicular Body Subunit 12B in the multivesicular body formation process. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
This small molecule non-competitive inhibitor of dynamin prevents the GTPase activity of dynamin, which is essential for vesicle scission from the membrane. As Multivesicular Body Subunit 12B is involved in vesicle formation, Dynasore's inhibition of vesicle release indirectly inhibits the functionality of Multivesicular Body Subunit 12B by disrupting vesicle trafficking. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
This cholesterol transport inhibitor disrupts intracellular cholesterol distribution affecting the endosomal/lysosomal trafficking system where Multivesicular Body Subunit 12B operates. By disrupting this system, the inhibitor indirectly hampers the function of Multivesicular Body Subunit 12B involved in the sorting of cargo into the intraluminal vesicles of multivesicular bodies. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
This non-competitive inhibitor of neutral sphingomyelinase prevents the hydrolysis of sphingomyelin to ceramide. Since ceramide is involved in the biogenesis of multivesicular bodies, inhibiting its production impairs the function of Multivesicular Body Subunit 12B, which is essential for the multivesicular body formation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
This raises the pH in intracellular vacuoles, including endosomes, disrupts the endosome's function where Multivesicular Body Subunit 12B operates. By increasing the pH, the inhibitor compromises the endosomal sorting complex required for transport (ESCRT) machinery, thereby inhibiting Multivesicular Body Subunit 12B's role in vesicle formation. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $217.00 | 6 | |
This inhibitor of phosphatidylinositol 4-kinase III beta (PI4KB) disrupts the phosphatidylinositol 4-phosphate synthesis, which is crucial for the function of the Golgi apparatus and endosomes. As Multivesicular Body Subunit 12B is involved in endosomal trafficking, inhibiting PI4KB indirectly inhibits the functionality of Multivesicular Body Subunit 12B. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
This ionophore disrupts pH gradients by exchanging protons for sodium ions across biological membranes. This disruption affects the endosomal sorting and maturation where Multivesicular Body Subunit 12B is active. By altering the pH, Monensin indirectly inhibits the function of Multivesicular Body Subunit 12B in the formation of multivesicular bodies. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
This tyrosine kinase inhibitor can interfere with the autophagy process by inhibiting the autophagosome formation. Since the autophagic pathway intersects with the endosomal pathway where Multivesicular Body Subunit 12B functions, Genistein indirectly inhibits the role of Multivesicular Body Subunit 12B in these processes. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
This inhibitor of ubiquitin-specific peptidase 10 (USP10) and USP13 deubiquitinates the endosomal protein Beclin1, leading to Beclin1 degradation. Since Beclin1 is involved in autophagosome formation, and Multivesicular Body Subunit 12B in endosomal sorting, Spautin-1's inhibition of Beclin1 indirectly inhibits Multivesicular Body Subunit 12B's functionality in vesicle trafficking. | ||||||